,i #aaith ,,congress #b;d ,session ,h4 ,r4 #hjjj ,,in ,,the ,,house ,,of ,,representatives ,march #ai1 #bjbf,mr4 ,bilirakis introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on the ,judiciary1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend the ,controlled ,substances ,act to schedule synthetic #g-;hydroxymitragynine as a ,schedule ,i controlled substance4 #a4 ,short title ,this ,act may be cited as the ,end ,needless ,distribution of #g-,,oh ,act or the ,,end #g-,,oh ,act4 #b4 ,scheduling of #g-;hydroxymitragynine ,schedule ,i1 as set forth in section #bjb7;c7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hab7;c771 is amended by adding at the end of subsection 7b7 of such schedule the following3 7#bc7 #g-;hydroxymitragynine-- 7,a7 including its synthetic equivalents2 but 7,b7 not including #g-;hydroxymitragynine naturally contained in the plant of the genus and species name3 ,mitragyna speciosa ,korth1 also known as kratom4 4